Optic gliomas: Past, present, and future

Research output: Contribution to journalArticle

Abstract

Our understanding of the clinical presentation, natural history, and responses to therapy of OPGs, both ONGs and OCGs, is steadily increasing. At the same time, the molecular biology and genetics of these tumors are becoming increasingly clear in both NF1 and non-NF1 patients. It is to be hoped that an understanding of these issues hopefully will lead to molecular therapies (?gene therapy, ?nanoparticles) to prevent or treat these lesions.

Original languageEnglish (US)
Pages (from-to)460-473
Number of pages14
JournalJournal of Neuro-Ophthalmology
Volume36
Issue number4
DOIs
StatePublished - 2016

Fingerprint

Optic Nerve Glioma
Molecular Biology
Natural History
Genetic Therapy
Nanoparticles
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Ophthalmology
  • Clinical Neurology

Cite this

Optic gliomas : Past, present, and future. / Miller, Neil R.

In: Journal of Neuro-Ophthalmology, Vol. 36, No. 4, 2016, p. 460-473.

Research output: Contribution to journalArticle

@article{77b75a2e5c4843fc9a784b6db6904236,
title = "Optic gliomas: Past, present, and future",
abstract = "Our understanding of the clinical presentation, natural history, and responses to therapy of OPGs, both ONGs and OCGs, is steadily increasing. At the same time, the molecular biology and genetics of these tumors are becoming increasingly clear in both NF1 and non-NF1 patients. It is to be hoped that an understanding of these issues hopefully will lead to molecular therapies (?gene therapy, ?nanoparticles) to prevent or treat these lesions.",
author = "Miller, {Neil R}",
year = "2016",
doi = "10.1097/WNO.0000000000000439",
language = "English (US)",
volume = "36",
pages = "460--473",
journal = "Journal of Neuro-Ophthalmology",
issn = "1070-8022",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Optic gliomas

T2 - Past, present, and future

AU - Miller, Neil R

PY - 2016

Y1 - 2016

N2 - Our understanding of the clinical presentation, natural history, and responses to therapy of OPGs, both ONGs and OCGs, is steadily increasing. At the same time, the molecular biology and genetics of these tumors are becoming increasingly clear in both NF1 and non-NF1 patients. It is to be hoped that an understanding of these issues hopefully will lead to molecular therapies (?gene therapy, ?nanoparticles) to prevent or treat these lesions.

AB - Our understanding of the clinical presentation, natural history, and responses to therapy of OPGs, both ONGs and OCGs, is steadily increasing. At the same time, the molecular biology and genetics of these tumors are becoming increasingly clear in both NF1 and non-NF1 patients. It is to be hoped that an understanding of these issues hopefully will lead to molecular therapies (?gene therapy, ?nanoparticles) to prevent or treat these lesions.

UR - http://www.scopus.com/inward/record.url?scp=84992734302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992734302&partnerID=8YFLogxK

U2 - 10.1097/WNO.0000000000000439

DO - 10.1097/WNO.0000000000000439

M3 - Article

C2 - 27798428

AN - SCOPUS:84992734302

VL - 36

SP - 460

EP - 473

JO - Journal of Neuro-Ophthalmology

JF - Journal of Neuro-Ophthalmology

SN - 1070-8022

IS - 4

ER -